Advertisement

Nuklearmedizinische Diagnostik

  • Christian PirichEmail author
  • Senta Graf
Chapter
  • 606 Downloads

Zusammenfassung

Nuklearmedizinische Verfahren nehmen seit Jahren einen wichtigen Stellenwert in der Abklärung kardiologischer Krankheitsbilder ein und sind daher auch für den Herzchirurgen von Bedeutung. Nuklearkardiologische Untersuchungstechniken sind wegen ihrer diagnostischen und prognostischen Aussagekraft, Zuverlässigkeit und Reproduzierbarkeit besonders in der Abklärung der koronaren Herzerkrankung (KHK) ein wichtiger diagnostischer Parameter. Konsequenterweise wurden die nuklearmedizinischen Verfahren in die Empfehlungen und Richtlinien zur Abklärung der KHK der amerikanischen (AHA/JACC) und europäischen (ESC) kardiologischen Fachgesellschaften aufgenommen (Marcassa et al. 2008; Montalescot et al. 2013). In dieser Übersicht findet sich eine klinisch orientierte Zusammenstellung der beiden bedeutendsten Einsatzgebiete nuklearkardiologischer Verfahren, der Myokardperfusionsszintigraphie (MPS) und myokardialen Vitalitätsdiagnostik. Für jede Indikationsgruppe werden die Methodik, die Befundung, die Aussagekraft sowie die Limitationen des entsprechenden nuklearkardiologischen Verfahrens dargestellt.

Literatur

  1. Agostini D, Marie PY, Ben-Haim S, Rouzet F, Songy B, Giordano A, Gimelli A, Hyafil F, Sciagrà R, Bucerius J, Verberne HJ, Slart RH, Lindner O, Übleis C, Hacker M, Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) (2016) Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the cardiovascular committee of the European Association of Nuclear Medicine (EANM). Eur J Nucl Med Mol Imaging 43:2423–2432PubMedGoogle Scholar
  2. Alexanderson E, García-Rojas L, Jiménez M, Jácome R, Calleja R, Martínez A, Ochoa JM, Meave A, Alexanderson G (2010) Effect of ezetimibe-simvastatine over endothelial dysfunction in dyslipidemic patients: assessment by 13N-ammonia positron emission tomography. J Nucl Cardiol 17:1015–1022PubMedGoogle Scholar
  3. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE (2002) Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39:1151–1158PubMedGoogle Scholar
  4. Bengel FM, Ueberfuhr P, Hesse T, Schiepel N, Ziegler SI, Scholz S, Nekolla SG, Reichart B, Schwaiger M (2002) Clinical determinants of ventricular sympathetic reinnervation after orthotopic heart transplantation. Circulation 106:831–835PubMedGoogle Scholar
  5. Bengel FM, Ueberfuhr P, Karja J, Schreiber K, Nekolla SG, Reichart B, Schwaiger M (2004) Sympathetic reinnervation, exercise performance and effects of beta-adrenergic blockade in cardiac transplant recipients. Eur Heart J 25:1726–1733PubMedGoogle Scholar
  6. Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Schalij MJ, Bax JJ (2010) Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 55:2769–2777PubMedGoogle Scholar
  7. Chang SM, Nabi F, Xu J, Raza U, Mahmarian JJ (2010) Normal stress-only versus standard stress/rest myocardial perfusion imaging: similar patient mortality with reduced radiation exposure. J Am Coll Cardiol 55:221–230PubMedGoogle Scholar
  8. Christou MA, Siontis GC, Katritsis DG, Ioannidis JP (2007) Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia. Am J Cardiol 99:450–456PubMedGoogle Scholar
  9. vom Dahl J, Eitzman DT, al-Aouar ZR, Kanter HL, Hicks RJ, Deeb GM, Kirsh MM, Schwaiger M (1994) Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 90:2356–2366Google Scholar
  10. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M (1994) Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 90:808–817PubMedGoogle Scholar
  11. Demer LL, Gould KL, Goldstein RA, Kirkeeide RL, Mullani NA, Smalling RW, Nishikawa A, Merhige ME (1989) Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients. Circulation 79:825–835PubMedGoogle Scholar
  12. Desideri A, Cortigiani L, Christen AI, Coscarelli S, Gregori D, Zanco P, Komorovsky R, Bax JJ (2005) The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 46:1264–1269PubMedGoogle Scholar
  13. Di Carli MF, Maddahi J, Rokhsar S, Schelbert HR, Bianco-Batlles D, Brunken RC, Fromm B (1998) Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg 116:997–1004PubMedGoogle Scholar
  14. Di Carli MF, Dorbala S, Curillova Z, Kwong RJ, Goldhaber SZ, Rybicki FJ, Hachamovitch R (2007) Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol 14:799–809PubMedGoogle Scholar
  15. Dorbala S, Vangala D, Sampson U, Limaye A, Kwong R, Di Carli MF (2007) Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study. J Nucl Med 48:349–358PubMedGoogle Scholar
  16. Esteves FP, Sanyal R, Santana CA, Shaw L, Raggi P (2008) Potential impact of noncontrast computed tomography as gatekeeper for myocardial perfusion positron emission tomography in patients admitted to the chest pain unit. Am J Cardiol 101:149–152PubMedGoogle Scholar
  17. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP et al (2012) ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 60:e44–e164PubMedGoogle Scholar
  18. Giorgetti A, Rossi M, Stanislao M, Valle G, Bertolaccini P, Maneschi A, Giubbini R, De Rimini ML, Mazzanti M, Cappagli M, Milan E, Volterrani D, Marzullo P, Myoview Imaging Optimization Group (2007) Feasibility and diagnostic accuracy of a gated SPECT early-imaging protocol: a multicenter study of the Myoview Imaging Optimization Group. J Nucl Med 48:1670–1675PubMedGoogle Scholar
  19. Graf S, Khorsand A, Gwechenberger M, Schütz M, Kletter K, Sochor H, Dudczak R, Maurer G, Pirich C, Porenta G, Zehetgruber M (2006) Myocardial perfusion in patients with typical chest pain and normal angiogram. Eur J Clin Investig 36:326–332Google Scholar
  20. Haas F, Haehnel CJ, Picker W, Nekolla S, Martinoff S, Meisner H, Schwaiger M (1997) Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 30:1693–1700PubMedGoogle Scholar
  21. Hattori N, Bengel FM, Mehilli J, Odaka K, Ishii K, Schwaiger M, Nekolla SG (2001) Global and regional functional measurements with gated FDG PET in comparison with left ventriculography. Eur J Nucl Med 28:221–229PubMedGoogle Scholar
  22. Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, Burkhard N, Wyss CA, Kaufmann PA (2009) Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 54:150–156PubMedGoogle Scholar
  23. Hida S, Chikamori T, Tanaka H, Usui Y, Igarashi Y, Nagao T, Yamashina A (2007) Diagnostic value of left ventricular function after stress and at rest in the detection of multivessel coronary artery disease as assessed by electrocardiogram-gated SPECT. J Nucl Cardiol 14:68–74PubMedGoogle Scholar
  24. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J, ADMIRE-HF Investigators (2010) Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 55:2212–2221PubMedGoogle Scholar
  25. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M (2005) Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril. Eur J Nucl Med Mol Imaging 32:964–971PubMedGoogle Scholar
  26. Kasama S, Toyama T, Sumino H, Nakazawa M, Matsumoto N, Sato Y, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M (2008) Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction. J Nucl Med 49:907–914PubMedGoogle Scholar
  27. Kasama S, Toyama T, Sumino H, Kumakura H, Takayama Y, Minami K, Ichikawa S, Matsumoto N, Sato Y, Kurabayashi M (2011) Prognostic value of cardiac sympathetic nerve activity evaluated by [123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction. Heart 97:20–26PubMedGoogle Scholar
  28. Landoni C, Lucignani G, Paolini G, Zuccari M, Galli L, Di Credico G, Rossetti C, Pelenghi S, Gilardi MC, Fazio F, Grossi A (1999) Assessment of CABG-related risk in patients with CAD and LVD. Contribution of PET with [18F]FDG to the assessment of myocardial viability. J Cardiovasc Surg 40:363–372Google Scholar
  29. Marcassa C, Bax JJ, Bengel F, Hesse B, Petersen CL, Reyes E, Underwood R, European Council of Nuclear Cardiology (ECNC), European Society of Cardiology Working Group 5 (Nuclear Cardiology and Cardiac CT), European Association of Nuclear Medicine Cardiovascular Committee (2008) Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement. Eur Heart J 29:557–563PubMedGoogle Scholar
  30. Meijboom WB, Van Mieghem CA, van Pelt N, Weustink A, Pugliese F, Mollet NR, Boersma E, Regar E, van Geuns RJ, de Jaegere PJ, Serruys PW, Krestin GP, de Feyter PJ (2008) Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina. J Am Coll Cardiol 52:636–643PubMedGoogle Scholar
  31. Montalescot G, Sechtem U, Achenbach S et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34:2949–3003. Erratum in: Eur Heart J. 2014;35:2260–2261PubMedPubMedCentralGoogle Scholar
  32. Nichols KJ, Van Tosh A, Wang Y, Chen J, Garcia EV, Palestro CJ, Reichek N (2009) Relationships between blood pool and myocardial perfusion-gated SPECT global and regional left ventricular function measurements. Nucl Med Commun 30:292–299PubMedPubMedCentralGoogle Scholar
  33. Parker MW, Iskandar A, Limone B, Perugini A, Kim H, Jones C, Calamari B, Coleman CI, Heller GV (2012) Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis. Circ Cardiovasc Imaging 5:700–707PubMedPubMedCentralGoogle Scholar
  34. Pazhenkottil AP, Benz DC, Gräni C, Madsen MA, Mikulicic F, von Felten E, Fuchs TA, Moch BH, Stehli J, Lüscher TF, Gaemperli O (2018) Hybrid SPECT perfusion imaging and coronary CT angiography: long-term prognostic value for cardiovascular outcomes. Radiology 288:694–702PubMedGoogle Scholar
  35. Pirich C, Schwaiger M (2000) The clinical role of positron emission tomography in management of the cardiac patient. Rev Port Cardiol 19:89–100Google Scholar
  36. Pirich C, Leber A, Knez A, Bengel FM, Nekolla SG, Haberl R, Schwaiger M (2004) Relation of coronary vasoreactivity and coronary calcification in asymptomatic subjects with a family history of premature coronary artery disease. Eur J Nucl Med Mol Imaging 31:663–670PubMedGoogle Scholar
  37. Pirich C, Keinrath P, Rettenbacher L, Rendl G, Holzmannhofer J, Hammerer M, Schuler J, Beheshti M (2014) 99mTc tetrofosmin myocardial perfusion scintigraphy in CAD. Performance with early and standard delayed acquisition and fractional flow reserve. Nuklearmedizin 53:111–116PubMedGoogle Scholar
  38. Pirich C, Keinrath P, Barth G, Rendl G, Rettenbacher L, Rodrigues M (2017) Diagnostic accuracy and functional parameters of myocardial perfusion scintigraphy using accelerated cardiac acquisition with IQ SPECT technique in comparison to conventional imaging. Q J Nucl Med Mol Imaging 61:102–107PubMedGoogle Scholar
  39. Rajappan K, Livieratos L, Camici PG, Pennell DJ (2002) Measurement of ventricular volumes and function: a comparison of gated PET and cardiovascular magnetic resonance. J Nucl Med 43:806–810PubMedGoogle Scholar
  40. Reyes E, Stirrup J, Roughton M, D’Souza S, Underwood SR, Anagnostopoulos C (2010) Attenuation of adenosine-induced myocardial perfusion heterogeneity by atenolol and other cardioselective beta-adrenoceptor blockers: a crossover myocardial perfusion imaging study. J Nucl Med 51:1036–1043PubMedGoogle Scholar
  41. Santana CA, Shaw LJ, Garcia EV, Soler-Peter M, Candell-Riera J, Grossman GB, Krawczynska EG, Faber TL, Ribera A, Vaccarino V, Halkar R, Di Carli MF (2004) Incremental prognostic value of left ventricular function by myocardial ECG-gated FDG PET imaging in patients with ischemic cardiomyopathy. J Nucl Cardiol 11:542–550PubMedGoogle Scholar
  42. Santana CA, Faber TL, Soler-Peter M, Sanyal R, Esteves FP, Ornelas M, Folks RD, Verdes L, Santana LF, Candell-Riera J, Garcia EV (2008) Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment. Nucl Med Commun 29:970–981PubMedGoogle Scholar
  43. Schenker MP, Dorbala S, Hong EC, Rybicki FJ, Hachamovitch R, Kwong RY, Di Carli MF (2008) Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation 117:1693–1700PubMedPubMedCentralGoogle Scholar
  44. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O’Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE, COURAGE Investigators (2008) Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117:1283–1291PubMedPubMedCentralGoogle Scholar
  45. Slart RH, Bax JJ, de Jong RM, de Boer J, Lamb HJ, Mook PH, Willemsen AT, Vaalburg W, van Veldhuisen DJ, Jager PL (2004) Comparison of gated PET with MRI for evaluation of left ventricular function in patients with coronary artery disease. J Nucl Med 45:176–182PubMedGoogle Scholar
  46. Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RA, de Boer J, Jager PL (2006) Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET. J Nucl Cardiol 13:210–219PubMedGoogle Scholar
  47. Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, Masuda M, Okuda K, Iwasaki Y, Yasui T, Hori M, Fukunami M (2009) Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. J Am Coll Cardiol 53:426–435PubMedGoogle Scholar
  48. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H (1986) Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 314:884–888PubMedGoogle Scholar
  49. Tsukamoto T, Morita K, Naya M, Katoh C, Inubushi M, Kuge Y, Tsutsui H, Tamaki N (2006) Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease. Eur J Nucl Med Mol Imaging 33:1150–1156PubMedGoogle Scholar
  50. Underwood SR, Bax JJ, vom Dahl J, Henein MY, Knuuti J, van Rossum AC, Schwarz ER, Vanoverschelde JL, van der Wall EE, Wijns W, Study Group of the European Society of Cardiology (2004) Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J 25:815–836PubMedGoogle Scholar
  51. Vanoverschelde JL, Wijns W, Depré C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA (1993) Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 87:1513–1523PubMedGoogle Scholar
  52. Verberne HJ, Acampa W, Anagnostopoulos C, Ballinger J, Bengel F, De Bondt P, Buechel RR, Cuocolo A, van Eck-Smit BL, Flotats A, Hacker M, Hindorf C, Kaufmann PA, Lindner O, Ljungberg M, Lonsdale M, Manrique A, Minarik D, Scholte AJ, Slart RH, Trägårdh E, de Wit TC, Hesse B, European Association of Nuclear Medicine (EANM) (2015) EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging 42:1929–1940PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, ein Teil von Springer Nature 2020

Authors and Affiliations

  1. 1.Universitätsklinik für Nuklearmedizin und Endokrinologie, Uniklinikum SalzburgParacelsus Medizinische PrivatuniversitätSalzburgÖsterreich
  2. 2.Universitätsklinik für Innere Medizin II, Abteilung für KardiologieMedizinische Universität WienWienÖsterreich

Personalised recommendations